In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE global surveillance programme 2015–2018
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 24, 249-256
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 12 references indexed in Scilit:
- Activity of ceftaroline against pathogens associated with community-acquired pneumonia collected as part of the AWARE surveillance program, 2015–2016Diagnostic Microbiology and Infectious Disease, 2019
- In vitro activity of Ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012–2014Diagnostic Microbiology and Infectious Disease, 2016
- In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance ProgramAntimicrobial Agents and Chemotherapy, 2016
- In vitroactivity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programmeJournal of Antimicrobial Chemotherapy, 2015
- Potential ofStaphylococcus aureusisolates carrying different PBP2a alleles to develop resistance to ceftarolineJournal of Antimicrobial Chemotherapy, 2015
- PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK: Table 1.Journal of Antimicrobial Chemotherapy, 2015
- Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint forStaphylococcus aureus: the role of PBP2a in the activity of ceftarolineJournal of Antimicrobial Chemotherapy, 2015
- Missense Mutations in PBP2A Affecting Ceftaroline Susceptibility Detected in Epidemic Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clonotypes ST228 and ST247 in Western Switzerland Archived since 1998Antimicrobial Agents and Chemotherapy, 2015
- A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: Susceptibility to ceftaroline and molecular epidemiologyInternational Journal of Antimicrobial Agents, 2015
- Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspectiveJournal of Antimicrobial Chemotherapy, 2014